Ariffin H, Daud S S, Mohamed Z, Ibrahim K, Lee T F, Chong L A
Department of Paediatrics, University of Malaya Medical Centre, Lembah Pantai, Kuala Lumpur 50603, Malaysia.
Singapore Med J. 2007 Apr;48(4):333-7.
The follow-up of chimerism status after allogeneic haematopoietic stem cell transplantation (HSCT) is essential to predict successful engraftment to assess the development of graft-versus-host disease, graft rejection and disease relapse. Analysis of short tandem repeats (STR) via polymerase chain reaction is frequently used for chimerism determination. However, most commercially-available kits have been designed for forensic purposes and may not be optimal for chimerism analysis. The present study aims to identify suitable STR markers for patient-donor pairs of predominantly Malay and Chinese ethnicity using two commercially-available forensic kits.
We analysed six STR loci, namely, CSF1PO, TPOX, TH01 (using the CTT multiplex system) and F13A01, FESFPS and vWA (using the FFv multiplex system) in 33 human leukocyte antigen-matched Malaysian patient-donor pairs to determine the suitability of these two multiplex systems for chimerism analysis in our local population.
Informativity (different alleles in donor and recipient) of each individual locus was TH01 73 percent, vWA 73 percent, F13A01 52 percent, CSF1PO 61 percent, FESFPS 39 percent and TPOX 45 percent. When combined, the six STR loci were able to give chimerism results in 31 out of 33 (94 percent) cases.
We found that TH01 and vWA are informative STR targets for post-HSCT chimerism analysis in predominantly Malay and Chinese patient-donor pairs. The commercially-available kits will also permit laboratories without extensive molecular biology capabilities to perform DNA typing in HSCT recipients.
异基因造血干细胞移植(HSCT)后对嵌合状态进行随访对于预测移植成功、评估移植物抗宿主病、移植排斥和疾病复发的发生至关重要。通过聚合酶链反应分析短串联重复序列(STR)常用于嵌合状态的测定。然而,大多数市售试剂盒是为法医目的设计的,可能并非最适合嵌合分析。本研究旨在使用两种市售法医试剂盒,为主要为马来族和华裔的患者-供体对鉴定合适的STR标记。
我们分析了33对人类白细胞抗原匹配的马来西亚患者-供体对中的6个STR位点,即CSF1PO、TPOX、TH01(使用CTT多重系统)以及F13A01、FESFPS和vWA(使用FFv多重系统),以确定这两种多重系统对我们当地人群嵌合分析的适用性。
每个单独位点的信息性(供体和受体中的不同等位基因)分别为TH01 73%(73%的供体和受体对在该位点具有不同等位基因)、vWA 73%、F13A01 52%、CSF1PO 61%、FESFPS 39%和TPOX 45%。综合起来,6个STR位点能够在33例中的31例(94%)中得出嵌合结果。
我们发现TH01和vWA是主要为马来族和华裔患者-供体对HSCT后嵌合分析的信息性STR靶点。市售试剂盒也将使没有广泛分子生物学能力的实验室能够对HSCT受者进行DNA分型。